Mandate

Vinge advises the Swedish government’s venture capital company, Fouriertransform

October 29, 2009

Vinge is assisting the Swedish government’s venture capital company for the automotive industry, Fouriertransform, in relation to its first investment. Fouriertransform has been formed to assist the automotive industry and is expected to make fifty investments within the next 15 months.

SEK 60 million is to be invested in Powercell Sweden AB which develops, produces and sells fuel cells, fuel reformers and auxillary power units.

Fouriertransform’s investment is occurring through a directed issue of new shares. Through Volvo Technology Transfer, AB Volvo remains the largest shareholder in Powecell Sweden AB with more than 40 per cent of the shares.

The Vinge team consisted of Ulf Sallnäs and Helena Jonsson.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026